Since melanoma cells express several chemokines, such as CCL2, CCL3, and CCL4,32 playing significant functional roles in the immune TME, we measured the effect of BRIRi on the expression of these chemokines at the transcriptome level. This evidence concerns the gene CCL2 and melanoma.